Article
Pushing the boundaries of brain organoids to study Alzheimer's disease.
Trends in molecular medicine - 1 Aug 2023
Cerneckis Jonas, Bu Guojun, Shi Yanhong
Abstract excerpt
Progression of Alzheimer's disease (AD) entails deterioration or aberrant function of multiple brain cell types, eventually leading to neurodegeneration and cognitive decline. Defining how complex cell-cell interactions become dysregulated in AD requires novel human cell-based in vitro platforms that could recapitulate the intricate cytoarchitecture and cell diversity of the human brain. Brain organoids (BOs) are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
